Literature DB >> 2088054

Ultrasound and the blood-brain barrier.

J T Patrick1, M N Nolting, S A Goss, K A Dines, J L Clendenon, M A Rea, R F Heimburger.   

Abstract

High intensity focused ultrasound was employed to modify the permeability of the normal feline and canine blood-brain barrier (BBB) to a circulating vital dye--Evans blue (EB). The threshold doses (W sec/cm2) for focally increasing the permeability of the BBB in white matter (WM) and gray matter (GM) were as follows: internal capsule (WM)--340 to 680; thalamus (GM)--approximately 1326; and caudate nucleus (GM)--2284 to 2952. In the presence of supralesioning doses of ultrasound, the cross sectional area occupied by the EB was consistently greater than that of the attendant nonhemorrhagic lesion--thus suggesting that BBB changes may be inducible at sublesioning doses. These findings, in conjunction with those of others, suggest that high intensity focused ultrasound may have a role in the treatment of brain tumors based on cell destruction by two mechanisms: (a) direct, by the ultrasound and (b) indirect, by an antineoplastic agent which is delivered via an ultrasonically modified BBB.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088054     DOI: 10.1007/978-1-4684-5766-7_36

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  20 in total

1.  Intracellular drug delivery using low-frequency ultrasound: quantification of molecular uptake and cell viability.

Authors:  K Keyhani; H R Guzmán; A Parsons; T N Lewis; M R Prausnitz
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  Ultrasound-enhanced drug transport and distribution in the brain.

Authors:  Ying Liu; Sumit Paliwal; Krystof S Bankiewicz; John R Bringas; Gill Heart; Samir Mitragotri; Mark R Prausnitz
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

Review 3.  Ultrasound enhanced drug delivery to the brain and central nervous system.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

Review 4.  Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

Authors:  Iason T Papademetriou; Tyrone Porter
Journal:  Ther Deliv       Date:  2015-08-25

Review 5.  Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.

Authors:  Linfeng Wu; Xiaoxun Li; Dileep R Janagam; Tao L Lowe
Journal:  Pharm Res       Date:  2013-08-31       Impact factor: 4.200

Review 6.  MR-guided focused ultrasound surgery, present and future.

Authors:  David Schlesinger; Stanley Benedict; Chris Diederich; Wladyslaw Gedroyc; Alexander Klibanov; James Larner
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

Review 7.  Ultrasound for drug and gene delivery to the brain.

Authors:  Kullervo Hynynen
Journal:  Adv Drug Deliv Rev       Date:  2008-04-06       Impact factor: 15.470

8.  Time-reversal Techniques in Ultrasound-assisted Convection-enhanced Drug Delivery to the Brain: Technology Development and In Vivo Evaluation.

Authors:  George K Lewis; Sabrina Guarino; Gaurav Gandhi; Laurent Filinger; George K Lewis; Willam L Olbricht; Armen Sarvazyan
Journal:  Proc Meet Acoust       Date:  2011-07-10

Review 9.  Focused Ultrasound for Neuromodulation.

Authors:  David P Darrow
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

Review 10.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Authors:  Muna Aryal; Costas D Arvanitis; Phillip M Alexander; Nathan McDannold
Journal:  Adv Drug Deliv Rev       Date:  2014-01-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.